Skip to main content

Effects of Qilin pills on spermatogenesis, reproductive hormones, oxidative stress, and the TSSK2 gene in a rat model of oligoasthenospermia



Qilin pills (QLPs), a classic Traditional Chinese Medicine (TCM) formula for treating male infertility, effectively improve semen quality in clinical trials. This study was designed to evaluate the effects of QLPs on spermatogenesis, reproductive hormones, oxidative stress, and the testis-specific serinekinase-2 (TSSK2) gene in a rat model of oligoasthenospermia.


Forty adult male Sprague-Dawley (SD) rats were randomly divided into four groups. The rat model with oligoasthenospermia was generated by intragastric administration of tripterygium glycosides (TGs) once daily for 4 weeks. Then, two treatment groups were given different doses (1.62 g/kg and 3.24 g/kg) of QLPs once daily for 60 days. Sperm parameters, testicular histology and reproductive hormone measurements, oxidative stress tests, and TSSK2 expression tests were carried out.


QLPs effectively improved semen parameters and testicular histology; restored the levels of FSH, LH, PRL, fT, and SHBG; reduced the levels of oxidative stress products (ROS and MDA); increased testicular SOD activity; and restored the expression of spermatogenesis-related gene TSSK2.


QLPs have a therapeutic effect on a rat model of oligoasthenospermia, and this effect is manifested as improvement of semen quality and testis histology, gonadal axis stability, decreased oxidative stress, and the regulation of testis-specific spermatogenesis-related gene TSSK2.

Peer Review reports


Human fertility has declined markedly due to various factors, such as ecological environmental pollution, an increase in work-related stress, unhealthy living habits, and sexually transmitted diseases [1,2,3,4]. The prevalence of infertility ranges from 10 to 15% among couples. Male factors are either directly or indirectly involved in approximately 50% of infertility cases [5, 6]. Oligoasthenospermia is the most common phenotype of male infertility in the clinic. The treatment of idiopathic oligoasthenospermia is mainly centered on experience-based therapeutic approaches, such as antioxidant and energy supplementation, which have limitations. Traditional Chinese Medicine (TCM) has certain advantages and characteristics in the treatment of idiopathic oligoasthenospermia [7, 8].

Qilin pills (QLPs), which are extensively used in China to treat men with oligoasthenospermia, especially idiopathic oligoasthenospermia, are a classic formula in TCM and contain 15 types of Chinese herbal medicines [9, 10]. The clinical efficacy of QLPs in the treatment of idiopathic oligoasthenospermia has recently been confirmed by two multicenter randomized controlled clinical trials (RCTs) [11, 12] and a meta-analysis [13]. Clinical observation has shown that QLPs can effectively improve semen quality and increase the pregnancy rate. Our previous animal-based study on protective effect of QLPs has also revealed that QLPs can significantly improve sperm concentration and motility and restore the testicular histology of rats with oligoasthenospermia [14, 15].

Many factors, such as urogenital infections, endocrine disorders, immunological factors and drug-related damage, affect the male reproductive system and lead to infertility [1, 2]. The specific mechanisms underlying the effects of these factors on male infertility may include spermatogenesis, hormone regulation, oxidative stress, and the regulation of spermatogenesis-related genes [16, 17].

Tripterygium glycosides (TGs) have been used to model spermatogenesis disorders in animals since 1980s in China [18]. Studies have shown that the antifertility effects of TGs are related to dysfunction of sperm cells, Sertoli cells, Leydig cells and spermatogenesis related genes [19, 20]. Ma et al. have explored the optimum dosage and time for establishing spermatogenic dysfunction rat model, with sperm concentration and motility, and pathological changes of testicular tissue used as evaluation criteria [21].

In this study, we designed an animal-based analysis to evaluate the therapeutic effects of QLPs on spermatogenesis, reproductive hormones, oxidative stress, and testis-specific serine kinase-2 (TSSK2) in a rat model of oligoasthenospermia.



QLPs were purchased from Guangdong Tai’antang Pharmaceutical Co., Ltd. (Guangdong, China). Chinese and Latin names of all herbal ingredients of QLPs were listed in Table 1. TGs tablets were purchased from Shanghai Fudan Fuhua Pharmacy Co., Ltd. (Shanghai, China). Testosterone (T), estradiol (E2), luteinizing hormone (LH), follicle stimulating hormone (FSH), free testosterone (fT), sex hormone binding globulin (SHBG), and prolactin (PRL) radioimmunoassay kits were purchased from Beijing Biosino Biotechnology and Science Incorporate (Beijing, China). Malondialdehyde (MDA), reactive oxygen species (ROS) and superoxide dismutase (SOD) assay kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).

Table 1 All herbal ingredients of QLPs


A total of 40, 8-week-old, Sprague-Dawley (SD) male rats weighing 270 ± 10 g were obtained from Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). The rats were acclimatized to standard housing conditions, including ambient temperature of 23 ± 2 °C, relative humidity at 60% ± 5%, and a 12-h light-dark cycle, in plastic cages (50 cm*35 cm*20 cm) for 1 week before initiation of the experiment. The rats were housed five per cage. The animals had free access to standard rodent chow and filtered water. The experimental protocols and ethics were approved by the Institutional Animal Care and Use Committee of the National Research Institute for Family Planning. All experiments were conducted with an effort to minimize the number of animals used and the physiological stress caused by the procedures employed.

Oligoasthenospermia model

The rat model of oligoasthenospermia was established according to previous experiments [21] by intragastrical administration of TGs once daily for 4 weeks at a dose of 40 mg/kg/d. The rats exhibited the characteristics of oligoasthenospermia in terms of testicular pathology and sperm concentration and motility [18, 21].

Experimental groups, treatment, and sample preparation

After the adaptation period, the animals were randomly divided into four groups containing 10 rats each. Physiological saline was continuously administered in the control group. The other 3 groups comprised the model control, low-dose QLPs, and high-dose QLPs groups. These groups were first treated with TGs to induce oligoasthenospermia, followed by physiological saline in the model control group, 1.62 g/kg QLPs (equivalent to the daily oral dose for patients based on body surface area) in the low-dose QLPs group, and 3.24 g/kg QLPs (double the low-dose QLPs treatment) in the high-dose QLPs group once daily for 60 days (equivalent to a cycle of spermatogenesis and maturation of rats). After the final treatment, the rats were weighed and anesthetized with CO2, and their testes and epididymides were removed by laparotomy and weighed. All efforts were made to minimize animals suffering, and euthanasia was performed by CO2 inhalation. The left testis of each animal was fixed in Bouin’s solution for immunohistochemical examination and the right testis was snap frozen in liquid nitrogen and stored at − 80 °C until the oxidative stress parameters, namely, the levels of MDA, ROS, and SOD, were measured. The blood serum was obtained by centrifugation (1500 rpm, 15 min, 4 °C) and stored at − 80 °C until use for biochemical determinations.

Analysis of sperm concentration and motility

The whole left epididymis of each rat was harvested immediately after sacrifice and cut into small pieces that were transferred to a tube containing 2 mL of warm (37 °C) phosphate-buffered saline (PBS) and 1 mL Medium 199 (Sigma, USA), which was shaken at 37 °C for 15 min to allow induce the sperm to swim. Then, 10 μL of diluted sperm suspension were transferred to each counting chamber of the hemocytometer to determine sperm concentration and motility which was measured as the percentage of motile sperm (a + b grade) in total spermatozoa [22].

Histopathological analysis

Testis tissue was fixed in Bouin’s solution for 48 h, routinely processed with an automatic tissue processor, dehydrated, embedded in paraffin, sectioned at 5-μm, and stained with hematoxylin and eosin (H&E). Cell morphology was observed under a light microscope (Nikon Eclipse TS100, Japan) and evaluated with Johnsen scoring [23]. The histological criteria for modified Johnsen scoring are as follows: full spermatogenesis (score 10), slightly impaired spermatogenesis, many late spermatids, disorganized epithelium (score 9), less than five spermatozoa per tubule, few late spermatids (score 8), no spermatozoa, no late spermatids, many early spermatids (score 7), no spermatozoa, no late spermatids, few early spermatids (score 6), no spermatozoa or spermatids, many spermatocytes (score 5), no spermatozoa or spermatids, few spermatocytes (score 4), spermatogonia only (score 3), no germinal cells, Sertoli cells only (score 2), and no seminiferous epithelium (score 1).

Detection of reproductive hormones

Serum stored at − 80 °C was thawed at room temperature. The hormonal analyses were performed using commercially available kits and in accordance with the manufacturer’s instructions.

Oxidative stress in testes

In view of the role of oxidative stress in male infertility, ROS, SOD, and MDA levels in the testes were tested [24, 25]. The testicular tissues were homogenized in 10× ice-cold PBS and centrifuged at 4000 rpm for 15 min. The supernatant were used to determine the ROS, SOD, and MDA levels in the testes, and these levels were determined using commercially available kits, in accordance with the manufacturer’s instructions.


The mRNA levels of spermatogenesis-related gene TSSK2 was determined by qRT-PCR. Total RNA was isolated using the TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. The quality of extracted RNA was verified by agarose gel electrophoresis and used to synthesize cDNA using the PrimeScript RT reagent kit with gDNA Eraser (Takara Bio, Japan). The sequences of primers are the following: TSSK2: forward primer 5′-CCGCAAGAAAACACCCACT-3′, reverse primer 5′-CTCGGCACTTGATGAACTCG-3′; GAPDH: forward primer 5′-TTCCTACC CCCAATGTATCCG-3′; reverse primer 5′-CCACCCTGTTGCTGTAGCCATA-3′. The thermal cycling conditions were 6 min at 95 °C, followed by 40 cycles of denaturation at 95 °C for 10 s, annealing at 58 °C for 10 s, and extension at 72 °C for 30 s. The expression levels of the mRNAs of each sample were normalized, with GAPDH serving as an internal control. The results were expressed as relative expression ratios with respect to the control group. The specificity of each primer was assessed by melting curve analysis. Data were analyzed with the 2−ΔΔCt method. All RT-PCRs were performed in triplicate and the data were presented as mean ± SD.

Western blot

Equal quantities of protein from the testis tissue lysate were processed for Western blotting (Roche, USA). Each sample was denatured, electrophoresed, and transferred onto a polyvinylidenedifluoride membrane. Specific steps were as follows: proteins were resolved by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis after denaturation at 95 °C for 5 min, and transferred to a polyvinylidenedifluoride membrane that was blocked overnight at 4 °C in PBS containing 0.1% Tween 20 (PBS-T) and 5% skim milk. The primary antibody used was rabbit anti-rat TSSK2 (1:500, Abcam, USA). After three washes with TBS-T, the membrane was incubated at room temperature for 1 h with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody (1:1000; Cell Signaling Technology) in PBS-T with 2% skim milk and washed three times with TBS-T. The blots were visualized with LumiGLO reagent and peroxide, followed by exposure to X-ray film. Western blot analyses were performed at least in triplicate.


Rat testis tissue was fixed by soaking in Bouin fixing fluid at room temperature for 48 h, and they then were dehydrated, embedded in paraffin, and cut into 5-μm-thick sections that were collected on glass slides. The sections were deparaffinized in xylene, rehydrated through a graded series of ethanol, and rinsed with water. Endogenous peroxidase activity was blocked by incubation in 0.3% hydrogen peroxide in PBS for 30 min at room temperature. The slides were blocked for 1 h in PBS supplemented with 10% normal goat serum. TSSK2 expression was detected after overnight incubation at 4 °C with antibodies against TSSK2 (1:200, Abcam, USA). After washing, the sections were incubated for 1 h with HRP-conjugated goat anti-rabbit IgG (1:2000; Santa Cruz Biotechnology, USA) in 10% goat serum, counterstained for 10s with hematoxylin (Gill no. 3; Sigma, USA). Imaging analyses was conducted using a confocal microscope (Nikon Eclipse TS100, Japan).

Statistical analysis

Data in accordance with the normal distribution are expressed as the mean ± standard deviation and were analyzed with SPSS software (version 22.0; Chicago, USA). Differences between group means were assessed by one-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls test. P < 0.05 was considered statistically significant.


General situation of experimental rats

In general, the rats in each group took normal food and water during the modeling and administration period. The consumption of food and water in rats increased gradually with body weight. There were no toxic symptoms such as nausea, sleepiness, sluggish reaction, hypokinesia, shedding of body hair, or obvious wasting. No rat died during modeling and administration.

QLPs streatment improves sperm quality

Results of semen parameters were shown in our previous paper [14]. Sperm concentration and motility were lower in model group than in control group (P < 0.05), indicating the successful establishment of the oligoasthenospermia rat model. Compared with the model group, sperm concentration and motility were increased by QLPs administration (P < 0.05). Sperm concentration but not sperm motility was higher in high-dose QLPs group than in low-dose QLPs group (P < 0.05).

QLPs treatment reverses histopathological damage

The cross section of testicular tissue is shown in Fig. 1a. It mainly includes the seminiferous tubules and the interstitium between tubules. Seminiferous tubules are the place where spermatozoa are produced, which are composed of Sertoli cells, spermatogonia, spermatocytes and spermatids. And interstitial tissue mainly includes blood vessels, lymphatic vessels, fibroblasts, macrophages, columnar cells and Leydig cells [26]. A histological analysis of testicular tissue from control group revealed a normal process of spermatogenesis, with a regular arrangement of spermatogenic epithelial cells in the seminiferous tubules. In contrast, the model group exhibited testicular damage including loss, disorganization, and sloughing of spermatogenic cells, degeneration of interstitial cells, and vacuolization in the cytoplasm of Sertoli cells, which were consistent with oligospermia. QLPs administration partly restored the morphology of Leydig, Sertoli, and spermatogenic cells, with the most dramatic improvement observed in high-dose QLPs group (Fig. 1a). There were significant differences in Johnsen scoring among groups (Fig. 1b).

Fig. 1

HE staining of testicular tissues and Johnsen scoring among groups. a The top line: magnification× 100; the bottom line: magnification× 200. Control group with normal histology of seminiferous tubules and interstitium. Oligoasthenospermia model group with loss of spermatogenic cells, degeneration of interstitial cells, and vacuolization in the cytoplasm of Sertoli cells. Low-dose QLPs group with increased numbers of spermatogenic cells, hyperplasia of interstitial cells, and decreased number of vacuoles in Sertoli cells. High-dose QLPs group with further enhancement of tissue recovery as compared to the low QLPs dose group. b Significant difference was found in Johnsen scoring among groups. (*P < 0.05 versus the control group; #P < 0.05 versus the model group; &P < 0.05 versus the low-dose QLPs group)

QLPs treatment regulates reproductive hormones

The concentrations of serum FSH, LH, PRL, fT, and SHBG were significantly higher in the model control group than in the other groups, while the values of the low-dose QLPs group were higher than those of the model group (Table. 2). However, no significant differences were evident between the concentrations of serum T in the groups, though the concentration of serum T was lower in the model group than in the other groups. Similarly, the E2 concentration was lower in the control groups than in the model and QLPs administration groups, and higher in the low-dose and high-dose QLPs groups than in the model group (Table. 2).

Table 2 Effects of QLPs on sex hormone level of the different groups of rats

QLPs treatment decreases oxidative stress

As shown in Table 3, the model rats pretreated with TGs alone showed high levels of ROS and MDA and a low level of SOD compared to the levels in the control group. The levels of SOD in the testes were significantly increased in the QLPs-treated group compared to the control group (P < 0.05; Table. 3). The activities of ROS and MDA increased in the TGs-treated group but decreased in the QLPs-treated group compared with the activities in the control group. However, compared to the model group, the ROS levels in the QLPs-treated groups were significantly decreased, and the SOD activities were increased.

Table 3 Comparison of oxidative stress indexes in rat testes

QLPs treatment recovers the mRNA level of TSSK2

Given the regulation effect of TSSK2 gene on spermatogenesis, qRT-PCR analysis was carried out to assess whether QLPs can modulate TSSK2 gene expression (Fig. 2a). The results show that the mRNA level of TSSK2 decreased in the model control group with oligoasthenospermia. Thus QLPs reversed the mRNA level of TSSK2 in treatment groups. Meantime, expression of TSSK2 at the mRNA level was significantly changed in high-dose QLPs group compared to low-dose QLPs group (Fig. 2b).

Fig. 2

Relative mRNA levels of spermatogenesis-related genes TSSK2. a Amplification plot and melting curve. b TSSK2 mRNA expression was sharply down-regulated in the oligoasthenospermia model group, while QLPs treatment reversed it. And the increase of TSSK2mRNA expression was more obvious in high-dose group. (*P < 0.05 versus the control group; #P < 0.05 versus the model group; &P < 0.05 versus the low-dose QLPs group)

QLPs treatment restores protein expression of TSSK2

Western blot analysis of protein expression showed that the TSSK2 levels were decreased in the model control group with oligoasthenospermia. However, this effect was reversed by the QLP treatments, suggesting QLP-mediated TSSK2 gene activation in the rat testes (Fig. 3a, b).

Fig. 3

Western blot analysis of TSSK2 protein expression. a Equal amounts of protein from the testis tissue lysates were analyzed for the expression of indicated proteins. b TSSK2 was sharply down-regulated in the oligoasthenospermia model control group, and this effect was reversed by the QLPs treatments. (*P < 0.05 versus the control group; #P < 0.05 versus the model group; &P < 0.05 versus the low-dose QLPs group)

Immunohistochemistry for the localization of TSSK2

The TSSK2 protein was expressed in spermatids and spermatogonia (Fig. 4a). TSSK2 immunoreactivity was lowest in the model control group and increased in a dose-dependent manner after QLP administration (Fig. 4b).

Fig. 4

Expression and location of TSSK2 proteins in testis tissue. a The top line: magnification× 200; the bottom line: magnification× 400. TSSK2 expression was detected by immunohistochemistry. TSSK2 was expressed in spermatids and spermatogonia. b TSSK2 expression was lower in the model control group with oligoasthenospermia than in the control and QLPs-treated groups. (*P < 0.05 versus the control group; #P < 0.05 versus the model group; &P < 0.05 versus the low-dose QLPs group)


In previous study, we confirmed that QLPs could clearly alleviate TGs-induced reproductive system damage by improving sperm quality and the histology of rat testis, effectively protecting reproductive function [14]. The therapeutic effect of QLPs on spermatogenesis function was confirmed in the present experiment also by improving sperm quality and testis histology. Sperm concentration and motility were increased by low- and high-dose QLP administration relative to oligoasthenospermia model group. QLP administration partly restored the morphology of Leydig, Sertoli, and spermatogenic cells damaged by TGs. Since studies have shown that spermatogenesis and maturation are regulated by the gonadal axis, affected by oxidative stress and spermatogenesis-related genes [27,28,29,30], the effects of QLPs on reproductive hormones, oxidative stress and spermatogenesis-related gene TSSK2 were evaluated in the present study.

In the present study, we used TGs to establish a rat model of oligoasthenospermia, which reflected the histopathological changes in the testis, abnormal sperm morphology, and reduced sperm motility. TGs induced atrophy of contorted seminiferous tubules, thinning of the seminiferous epithelium, and reduced the number of spermatogenic cells, resulting in decreased sperm concentration and motility sperm in the epididymis. These changes related to necrosis and aseptic inflammation was consistent with the study carried out by Ma HF [21]. QLPs administration partly restored the morphology of Leydig, Sertoli, and spermatogenic cells, which was the base of spermatogenesis. It was also verified by data gained from our previous study about the protective effect of QLPs on the reproductive function [14]. Johnsen scoring was used to assess the change of testicular histology in the present study. Significant difference was found among groups, which revealed the success of tablishing spermatogenic dysfunction rat model by TGs and the therapeutical effect of QLPs on pathologic testis.

Reproductive hormone, especially serum FSH, LH, and T, plays roles in the maintenance of male reproductive function. Testicular activity is governed by testicular T and gonadotrophic hormones (FSH and LH). LH stimulates the release of T from Leydig cells, and FSH regulates the production of spermatozoa by acting on Sertoli cells [31]. In this study, increased serum FSH and LH levels were observed in the TGs-induced model control group. However, there was no significant difference in FSH and LH levels between the high dose QLP group and the model group. Possible reasons for this were as follows. Due to the damage effect of TGs, spermatogenic function was impaired, which caused the regulation of gonadal axis to make FSH and LH elevated in model group. In the high-dose QLPs group, QLPs itself positively regulated hormones and increased the level of FSH and LH.

Although the serum T levels exhibited a downward trend without statistical significance, the results revealed the effect of TGs on the gonadal axis. The analysis showed that the serum LH, FSH and T levels remained normal after the administration of QLPs, indicating that QLPs could restore the balance of the gonadal axis. A normal gonadal axis is important for the recovery and maintenance of spermatogenesis. A compensatory increase in serum LH levels directly stimulated T production (manifested as the increased level of fT) from Leydig cells in the model control group of our studies, which was consistent with the study by Wisniewski P [32]. As shown in previously published data, a decrease in serum T levels is related to the severity of spermatogenic cell damage, disordered spermatogenesis and a decline in sperm quality and can therefore cause oligoasthenospermia [33].

Under physiological conditions, PRL and LH stimulate the production of steroids. Elevated prolactin in a short term may promote the secretion of ketones, but long-term hyperprolactinemia can reduce the production of ketones and destroy sperm production [34]. In animal models, PRL also regulates spermatogenesis. PRL induces the expression of FSH in Sertoli cells and stimulates the progression of germ cells from spermatocyte to spermatid [35]. In the model control group of this study, PRL increased significantly and positively regulated FSH to a higher level, resulting in disordered spermatogenesis. After treatment with QLPs, the levels of serum PRL and FSH in the damaged rats gradually recovered.

Testicular T concentrations play a central role in maintaining normal spermatogenesis. Low testicular T levels can impair spermatogenesis. However, elevated E2 levels inhibit pituitary gonadotropin secretion, resulting in down-regulation of Leydig cell function, decreased T production and decreased T levels in both the testis and serum [36]. The balance between serum androgen and estrogen levels is essential for maintaining normal spermatogenesis by means of the serum levels of SHBG, which transports androgens and estrogens in blood and regulates steroid access to target tissues. In this study, the levels of serum SHBG in the QLP treatment groups were decreased, which together with higher androgen levels, played the role of T pool, thereby maintaining the stability of biologically active serum T levels and ensuring the spermatogenesis process.

Some male infertility patients with severe spermatogenesis impairments present with strong aromatase activity, which is characterized by relatively low serum T levels and elevated E2 levels [37, 38]. In the model control group of the present study, relatively decreased T levels were due to the decreased synthesis of testicular T in the testis or to increased metabolic clearance of serum T. Increased metabolic clearance of serum T by the stimulation of aromatase, a key enzyme in the conversion of T to E2, leads to an increase in E2 levels. The statistically significant increase in the E2 levels of the QLP treatment groups in our study are not consistent with the observations of previous studies [14], and this discrepancy may be related to excessive aromatase enzyme activity during spermatogenesis.

By examining the influence of the gonadal axis, we found that QLPs could significantly restore the levels of sex hormone, except for E2 and fT. The balancing effects of QLPs on reproductive hormones were helpful toward maintaining normal spermatogenesis, sperm concentrations and sperm vitality. Based on the observation of a spermatogenic cycle in the rats after QLP treatment, during which the recovery of pituitary hormones was faster than that of testicular hormones, the results failed to fully reflect the treatment effects of QLPs.

Oxidative stress, which disrupts the steady state relationship between the production of ROS and the antioxidant defensive capacity of the body, is an important factor that contributes to the loss of sperm motility and to male infertility [39]. Under physiological conditions, ROS are formed during oxygen metabolism, and ROS concentrations are controlled by antioxidant defense mechanisms, such as SOD. However, the overproduction of ROS may result in oxidative stress that has a significant adverse impact on semen quality and male fertility [40]. Increased oxidative stress causes a decrease in intracellular ATP levels and the release of apoptogenic factors (pro-caspase cytochrome C, apoptosis-inducing factors) into the cytosol as a result of mitochondrial membrane disruption, enzyme dysfunction, protein phosphorylation disruption, increased membrane permeability, and spermicidal products formation, thereby decreasing semen quality [39]. The spermatogenic cell membrane and sperm cells are very susceptible to attack by ROS-mediated oxidative damage since these components are rich in polyunsaturated fatty acids, and this damage may result in decreased sperm motility [40].

Since the generation of low levels of ROS is an important component of the signal-transduction-stimulating capacity of spermatozoa [41], excessive ROS levels induce lipid peroxidation of the sperm cell membrane, the malfunction of capacitation, impaired acrosome reactions, and a loss of motility [42]. Lipid oxidation products, including MDA, are reliable biomarkers of oxidative stress [43]. In the current study, TG-induced reproductive toxicity was associated with elevated oxidative stress in testes, as evidenced by the increased levels of testicular ROS and MDA.

Increased lipid peroxidation and altered membrane function can affect sperm motility and cause sperm dysfunction, which may be a consequence of a rapid loss of intracellular ATP leading to decreased sperm viability [44]. ROS is capable of disrupting the androgen-producing Leydig cells and may cause increased lipid peroxidation and DNA fragmentation in germ cells. Antioxidant enzymes provide the first line of defense against the deleterious effects of ROS [45]. SOD catalyzes the dismutation of superoxide radicals to hydrogen peroxide (H2O2) and molecular oxygen, whereas catalase (CAT) and glutathioneperoxidase (GSH-PX) are responsible for H2O2 detoxification [46]. The decreased activity of SOD leads to the increased production of MDA via the catalytic cracking of lipid peroxides in the presence of metal ions. MDA is toxic to cells and can form intramolecular and intermolecular cross-linkages with proteins to induce apoptosis [47].

In the present investigation, the testes of the TGs-treated rats showed significantly decreased testicular SOD activity, which further led to significantly increased lipidperoxidation in the testes. Lipid peroxidation is one of the primary processes that result from oxidative stress. The QLP treatments resulted in enhanced antioxidative enzyme activities, thereby suppressing lipid peroxidation and thus rescuing the testes from the TGs-induced oxidative load. In summary, compared to the model group, the ROS levels in the QLPs-treated groups were significantly decreased, and the SOD activities were increased. These results suggested that the oxidative stress products were effectively scavenged after QLP treatments and that the treatment improved the testes antioxidant ability.

Spermatogenesis is a complex process involving specific interactions between the developing germ cells and their support cells, namely, Sertoli cells, within the seminiferous tubules. This process is regulated by androgen-producing Leydig cells, which are located in the interstitial tissue surrounding the seminiferous tubules. The molecular mechanisms regulating spermatogenesis are largely unknown; however, several kinases have been implicated in various stages of spermatogenesis, primarily in the control of meiosis [48]. TSSK2, a member of the TSSK family, is expressed exclusively during the cytodifferentiation of late spermatids tosperms [49, 50]. Therefore, TSSK2, a specific phosphorylated protein of testicular tissue, can be used to detect spermatogenesis in testicular tissue. In our study, the expression of TSSK2 was examined in each group by qRT-PCR, western blot and immunohistochemistry. TSSK2 expression in the model control group was significantly weakened. However, TSSK2 expression gradually recovered after the treatments with QLPs, indirectly demonstrating the role of QLPs in regulating the expression of spermatogenic genes.

The specific mechanism by which QLPs regulate the reproductive system is still unclear. The effects of QLPs on semen quality, testicular pathology, reproductive hormones, oxidative stress and spermatogenesis-related gene TSSK2 were associated with the ingredients of QLPs. Lycium chinense Mill. plays a significant role in the recovery of serum testosterone levels, increased superoxide dismutase activity, decreased malondialdehyde levels, promoted oxidative balance and rescued testicular DNA damage [51]. Cuscuta chinensis Lam. increased the weights of testis, epididymis and pituitary gland, and stimulated T and LH secretion both in vitro and in immature rats [52]. And Epimedium brevicornu Maxim. exerted beneficially protective effects on the structural and functional damage of male mice reproductive system and reduced apoptosis in spermatogenic cells by inhibiting oxidative stress [53]. The protection and regulatory role of QLPs on reproductive function is the result of synergistic effect of various components of QLPs. We initially explored the possible molecular mechanism of QLPs on alleviating oligoasthenospermia [15]. Our previous studies revealed that the improvement function of QLPs on sperm and testis works mainly by suppressing mitochondrial apoptosis in the testis via modulation of B cell lymphoma (Bcl)-2, Bcl-2-associated X protein (Bax), cytochrome C, caspase-9 and caspase-3 expression. But beyond that, other specific mechanism of the QLPs on the reproductive system still needs further research.


QLPs have effects on the entire spermatogenesis process, and these effects are not only manifested in maintaining the balance of reproductive hormones but also in reducing oxidative stress, which can inhibit spermatogenic cell apoptosis. In addition, QLPs also have regulatory effects on spermatogenesis-related genes, which directly affect the process of spermatogenesis.

Availability of data and materials

The datasets used and/or analyzed for this study are available from the corresponding author by reasonable request.




E2 :



Follicle stimulating hormone


Free testosterone


Glyceraldehyde 3-phosphate dehydrogenase



H2O2 :

Hydrogen peroxide


Luteinizing hormone




Phosphate-buffered saline




Qilin pill


Randomized controlled clinical trial


Reactive oxygen species


Sex hormone binding globulin


Superoxide dismutase




Traditional Chinese Medicine


Tripterygium glycosides


The testis-specific serinekinase-2


  1. 1.

    Kesari KK, Agarwal A, Henkel R. Radiations and male fertility. Reprod Biol Endocrinol. 2018;16(1):118.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Agarwal A, Rana M, Qiu E, AlBunni H, Bui AD, Henkel R. Role of oxidative stress, infection and inflammation in male infertility. Androl. 2018;50(11):e13126.

    Article  CAS  Google Scholar 

  3. 3.

    Fode M, Fusco F, Lipshultz L, Weidner W. Sexually transmitted disease and male infertility: a systematic review. Eur Urol Focus. 2016;2(4):383–93.

    PubMed  Article  Google Scholar 

  4. 4.

    Segal TR, Giudice LC. Before the beginning: environmental exposures and reproductive and obstetrical outcomes. Fertil Steril. 2019;112(4):613–21.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Jungwirth A. Diemer T. Giwercman A, Kopa Z, Krausz C, Tournaye H. EAU guidelines on male infertility. European Association of Urology: Dohle GR; 2013.

    Google Scholar 

  6. 6.

    Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e1001356.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Wang SC, Wang SC, Li CJ, Lin CH, Huang HL, Tsai LM, Chang CH. The therapeutic effects of Traditional Chinese Medicine for poor semen quality in infertile males. J Clin Med. 2018;7(9). pii: E239.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  8. 8.

    Jiang D, Coscione A, Li L, Zeng BY. Effect of Chinese herbal medicine on male infertility. Int Rev Neurobiol. 2017;135:297–311.

    PubMed  Article  Google Scholar 

  9. 9.

    Duan Q, Zhuang YX, Yao LM, Cao J. Qualitative and quantitative method for Kirin pills. Cen S Pharm. 2012;10(12):919–22.

    CAS  Google Scholar 

  10. 10.

    Zhuang YX, Chen WQ, Cai ZC. Preparation and clinical application of Qilin pills. J Chin Med Mater. 2004;27(9):708–9.

    Google Scholar 

  11. 11.

    Shang XJ, Guo J, Chen L, Deng CH, Sun XZ, Geng Q, Zhou SH, Mao XM, Deng JH, Yang H, Huang YF. Qilin pills for oligoasthenospermia: a multi-centered clinical trial. Zhonghua Nan Ke Xue. 2011;17(12):1139–42.

    PubMed  Google Scholar 

  12. 12.

    Mao JM, Jiang H, Wang CH, Ning KQ, Liu JH, Yang SW, Li HS, Zhou SH, Zhang ZC, Xu JX, Huang YH. Qilin pills for idiopathic oligoasthenospermia: a multi-centered randomized double-blind controlled clinical trial. Zhonghua Nan Ke Xue. 2017;23(3):251–5.

    PubMed  Google Scholar 

  13. 13.

    Jin X, Man CF, Gong DD, Fan Y. Adjuvant treatment with Qilin pill for men with oligoasthenospermia: a meta-analysis of randomized controlled trials. Phytother Res. 2017;31(9):1291–7.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Zhang KS, Zhou F, An Q, Jia YF, Fu LL, Lu WH, Liang XW, Shang XJ, Gu YQ. Protective effect of Qilin pills on the reproductive function of oligoasthenospermia rats. Zhonghua Nan Ke Xue. 2017;23(9):821–7.

    PubMed  Google Scholar 

  15. 15.

    Zhang K, Ge Z, Fu L, An Q, Zhou F, Guo Y, Wang X, Lu W, Liang X, Wang S, Shang X, Gu Y. Qilin pills alleviate oligoasthenospermia by inhibiting Bax-caspase-9 apoptosis pathway in the testes of model rats. Oncotarget. 2018;9(31):21770–82.

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Zhou SH, Deng YF, Weng ZW, Weng HW, Liu ZD. Traditional Chinese medicine as a remedy for male infertility: a review. World J Mens Health. 2019;37(2):175–85.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Moghbelinejad S, Mozdarani H, Ghoraeian P, Asadi R. Basic and clinical genetic studies on male infertility in Iran during 2000-2016: a review. Int J Reprod Biomed (Yazd). 2018;16(3):131–48.

    CAS  Google Scholar 

  18. 18.

    Mao PM, Li HS, Wang B, Mo XW. Research progress in preparation of tripterygium glycosides-induced infertility animal model. Chin J Integr Trad West Med. 2015;35(2):254–5.

    CAS  Google Scholar 

  19. 19.

    Hu L, Xu HM, Xiong JW, Tian YH, Ming Y, Xiong F, Xiong CL. Resistant effect of water decoction of root of Crataegus cuneata on male infertility induced by GTW in rats. Zhongguo Zhong Yao Za Zhi. 2006;31(18):1521–5.

    PubMed  Google Scholar 

  20. 20.

    Ma B, Qi H, Li J, Xu H, Chi B, Zhu J, Yu L, An G, Zhang Q. Triptolidedisrupts fatty acids and peroxisome proliferator-activated receptor (PPAR) levels in male mice testes followed by testicular injury: a GC-MS based metabolomics study. Toxicol. 2015;336:84–95.

    CAS  Article  Google Scholar 

  21. 21.

    Ma HF, Li HS, Zhao ZJ, Wang B, Zhao B, Mo XW, Liu Y, Cheng MX, Yang MJ. Establishment of rat model for spermatogenesis disorder induced by tripterygium glycosides. Zhonghua Nan Ke Xue. 2015;21(2):179–84.

    CAS  Google Scholar 

  22. 22.

    Xu YP, Liu BX, Zhang XP, Yang CW, Wang CH. A Chinese herbal formula, Wuzi Yanzong pill, improves spermatogenesis by modulating the secretory function of Sertoli cells. Chin J Integr Med. 2014;20(3):194–9.

    PubMed  Article  Google Scholar 

  23. 23.

    Johnsen SG. Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Horm Res Paediatr. 1970;1:2–25.

    CAS  Article  Google Scholar 

  24. 24.

    Wagner H, Cheng JW, Ko EY. Role of reactive oxygen species in male infertility: An updated review of literature. Arab J Urol. 2017;16(1):35–43.

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Obembe OO, Olatoke TF, Atere TG. Reproductive indices and oxidative stress biomarkers of male Wistar rats prenatally exposed to cigarette smoke. Niger J Physiol Sci. 2019;34(1):91–8.

    CAS  PubMed  Google Scholar 

  26. 26.

    Zhou R, Wu J, Liu B, Jiang Y, Chen W, Li J, He Q, He Z. The roles and mechanisms of Leydig cells and myoid cells in regulating spermatogenesis. Cell Mol Life Sci. 2019;76(14):2681–95.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Geng X, Shao H, Zhang Z, Ng JC, Peng C. Malathion-induced testicular toxicity is associated with spermatogenic apoptosis and alterations in testicular enzymes and hormone levels in male Wistar rats. Environ Toxicol Pharmacol. 2015;39(2):659–67.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Lakpour N, Mahfouz RZ, Akhondi MM, Agarwal A, Kharrazi H, Zeraati H, Amirjannati N, Sadeghi MR. Relationship of seminal plasma antioxidants and serum male hormones with sperm chromatin status in male factor infertility. Syst Biol Reprod Med. 2012;58(5):236–44.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Salomon TB, Hackenhaar FS, Almeida AC, Schüller AK, Gil Alabarse PV, Ehrenbrink G, Benfato MS. Oxidative stress in testis of animals during aging with and without reproductive activity. Exp Gerontol. 2013;48(9):940–6.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Hao Z, Jha KN, Kim YH, Vemuganti S, Westbrook VA, Chertihin O, Markgraf K, Flickinger CJ, Coppola M, Herr JC, Visconti PE. Expression analysis of the human testis-specific serine_threonine kinase (TSSK) homologues. A TSSK member is present in the equatorial segment of human sperm. Mol Hum Reprod. 2004;10(6):433–44.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Walker WH. Testosterone signaling and the regulation of spermatogenesis. Spermatogenesis. 2011;1(2):116–20.

    PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Wisniewski P, Romano RM, Kizys MM, Oliveira KC, Kasamatsu T, Giannocco G, Chiamolera MI, Dias-da-Silva MR, Romano MA. Adult exposure to bisphenol a (BPA) in Wistar rats reduces sperm quality with disruption of the hypothalamic-pituitary-testicular axis. Toxicol. 2015;2(329):1–9.

    Article  CAS  Google Scholar 

  33. 33.

    Lin JF, Lin YH, Liao PC, Lin YC, Tsai TF, Chou KY, Chen HE, Tsai SC, Hwang TI. Induction of testicular damage by daily methamphetamine administration in rats. Chin J Physiol. 2014;57(1):19–30.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Rastrelli G, Corona G, Maggi M. The role of prolactin in andrology: what is new? Rev Endocr Metab Disord. 2015;16(3):233–48.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Gunasekar PG, Kumaran B, Govindarajulu P. Role of prolactin on leydig, sertoli and germ cellular neutral lipids in bonnet monkeys, macaca radiate. Endocrinol Jpn. 1991;38(1):1–8.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Ring JD, Lwin AA, Köhler TS. Current medical management of endocrine-related male infertility. Asian J Androl. 2016;18(3):357–63.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Safarinejad MR, Shafiei N, Safarinejad S. Association of the (TAAAA) n repeat and Asp327Asn polymorphisms in the sex hormone-binding globulin (SHBG) gene with idiopathic male infertility and relation to serum SHBG concentrations. J Steroid Biochem Mol Biol. 2011;123(1–2):37–45.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  38. 38.

    Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol. 2011;165(3):837–41.

    Article  Google Scholar 

  39. 39.

    Fanaei H, Khayat S, Halvaei I, Ramezani V, Azizi Y, Kasaeian A, Mardaneh J, Parvizi MR, Akrami M. Effects of ascorbic acid on sperm motility, viability, acrosome reaction and DNA integrity in teratozoospermic samples. Iran J Reprod Med. 2014;12(2):103–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Turner TT, Lysiak JJ. Oxidative stress: a common factor in testicular dysfunction. J Androl. 2008;29(5):488–98.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Ford WC. Regulation of sperm function by reactive oxygen species. Hum Reprod Update. 2004;10(5):387–99.

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Aitken RJ, Smith TB, Jobling MS, Baker MA, De Iuliis GN. Oxidative stress and male reproductive health. Asian J Androl. 2014;16(1):31–8.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329(1–2):23–38.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Cummins JM, Jequier AM, Kan R. Molecular biology of human male infertility: links with aging, mitochondrial genetics, and oxidative stress? Mol Reprod Dev. 1994;37(3):345–62.

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab. 2005;6(5):495–501.

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Sciegienka SJ, Solst SR, Falls KC, Schoenfeld JD, Klinger AR, Ross NL, Rodman SN, Spitz DR, Fath MA. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediatedoxidative stress. Free Radic Biol Med. 2017;108:354–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  47. 47.

    Jana K, Samanta PK, De DK. Nicotine diminishes testicular gametogenesis, steroidogenesis and steroidogenic acute regulatory protein expression in adult albino rats: possible influence on pituitary gonadotropins and alteration of testicular antioxidant status. Toxicol Sci. 2010;116(2):647–59.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Sassone-Corsi P. Transcriptional checkpoints determining the fate of male germ cells. Cell. 1997;88(2):163–6.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Kueng P, Nikolova Z, Djonov V, Hemphill A, Rohrbach V, Boehlen D, Zuercher G, Andres AC, Ziemiecki A. A novel family of serine/threonine kinases participating in spermiogenesis. J Cell Biol. 1997;139(7):1851–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Zhang H, Su D, Yang Y, Zhang W, Liu Y, Bai G, Ma M, Ma Y, Zhang S. Some single-nucleotide polymorphisms of the TSSK2 gene may be associated with human spermatogenesis impairment. J Androl. 2010;31(4):388–92.

    PubMed  Article  CAS  Google Scholar 

  51. 51.

    Luo Q, Cui X, Yan J, Yang M, Liu J, Jiang Y, Li J, Zhou Y. Antagonistic effects of Lyciumbarbarum polysaccharides on the impaired reproductive system of male rats induced by local subchronic exposure to 60Co-γ irradiation. Phytother Res. 2011;25(5):694–701.

    CAS  PubMed  Article  Google Scholar 

  52. 52.

    Qin DN, She BR, She YC, Wang JH. Effects of flavonoids from semen Cuscutae on the reproductive system in male rats. Asian J Androl. 2000;2(2):99–102.

    CAS  PubMed  Google Scholar 

  53. 53.

    Yuan D, Wang H, He H, Jia L, He Y, Wang T, Zeng X, Li Y, Li S, Zhang C. Protective effects of total flavonoids from Epimedium on the male mouse reproductive system against cyclophosphamide-induced oxidative injury by up-regulating the expressions of SOD3 and GPX1. Phytother Res. 2014;28(1):88–97.

    CAS  PubMed  Article  Google Scholar 

Download references


The authors wish to thank Zhengyan Ge, Fang Zhou, Xiaowei Wang, Changyong Zhang and Guo Bao for their help with animal experiments.


This research was supported by Science and Technology Projects of National Research Institute for Family Planning, China (No. 2017JY004). Funds have been used in areas such as experimentation, analysis and interpretation of data. This funding body was not involved in the design of the study or collection, analysis, or interpretation of data or in writing manuscript.

Author information




KSZ, YQG and XJS performed study concept and design; KSZ, LLF, and QA performed analysis and interpretation of data; KSZ drafted the paper; WHL, XWL, WHH, JXL, XMT and YD performed critical revision of the paper for important intellectual content; XJS and YQG performed study supervision. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xuejun Shang or Yiqun Gu.

Ethics declarations

Ethics approval and consent to participate

Experimental procedures were in accordance with the Ethical Principles of Animal Research and were approved by the National Research Institute for Family Planning Ethics Committee for Animal Research (Approval Number: 2017–1112-01).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, K., Fu, L., An, Q. et al. Effects of Qilin pills on spermatogenesis, reproductive hormones, oxidative stress, and the TSSK2 gene in a rat model of oligoasthenospermia. BMC Complement Med Ther 20, 42 (2020).

Download citation


  • Traditional Chinese medicine
  • Qilin pills
  • Male infertility
  • Tripterygium glycosides
  • TSSK2